Nuzenio

Iovance Biotherapeutics Reports

Iovance Biotherapeutics Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 5 publisher sources 100/100 entity strength

Latest news

State Street Corporation (NYSE: STT) discloses 5.5% Iovance Biotherapeutics stake - Stock TitanStock Titan · Fri, 07 Aug 2026 13:57:10 GMTWhy Did IOVA, REPL, ROKU Stocks Surge To 52-Week Highs Today? - TradingViewTradingView · Fri, 07 Aug 2026 02:40:00 GMTIovance Biotherapeutics Reports Record Q2 Revenue and Reviews 2026 Outlook on Strong Amtagvi Demand - finance.yahoo.comfinance.yahoo.com · Thu, 06 Aug 2026 14:54:49 GMTIovance Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 13:32:06 GMTIovance Biotherapeutics (NASDAQ: IOVA) posts Q2 2026 $99.3M revenue - Stock TitanStock Titan · Thu, 06 Aug 2026 13:16:31 GMTIovance Biotherapeutics reports record Q2 revenue ~$99.3M, gross margin 56% - TradingViewTradingView · Thu, 06 Aug 2026 11:13:01 GMTIovance Biotherapeutics Reports Record Second Quarter 2026 - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 11:01:00 GMTIOVA Stock Price, Quote & Chart - ChartMillChartMill · Mon, 27 Jul 2026 14:37:07 GMT

Timeline

Fri, 07 Aug 2026 13:57:10 GMTState Street Corporation (NYSE: STT) discloses 5.5% Iovance Biotherapeutics stake - Stock Titan
Fri, 07 Aug 2026 02:40:00 GMTWhy Did IOVA, REPL, ROKU Stocks Surge To 52-Week Highs Today? - TradingView
Thu, 06 Aug 2026 14:54:49 GMTIovance Biotherapeutics Reports Record Q2 Revenue and Reviews 2026 Outlook on Strong Amtagvi Demand - finance.yahoo.com
Thu, 06 Aug 2026 13:32:06 GMTIovance Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView
Thu, 06 Aug 2026 13:16:31 GMTIovance Biotherapeutics (NASDAQ: IOVA) posts Q2 2026 $99.3M revenue - Stock Titan
Thu, 06 Aug 2026 11:13:01 GMTIovance Biotherapeutics reports record Q2 revenue ~$99.3M, gross margin 56% - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Iovance Biotherapeutics Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.